Assignee
MALLINCKRODT PHARMACEUTICALS IRELAND LTD
IE·45 granted patents·37 pending applications·57 citations·filing 2016–2025
Top patents by PatentIndex Score
82 records- 0197US11998689B2Enhanced performance verification port for therapeutic gas deliveryMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2021·Granted Jun 4, 2024·8 cites·21 claims
- 0296US11950590B2Methods to improve organ viabilityMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2021·Granted Apr 9, 2024·2 cites·13 claims
- 0395US11744976B2Apparatus and method for detecting liquid level in a clear or partially clear containerMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Granted Sep 5, 2023·2 cites·5 claims
- 0495US2026069814A1Apparatus and method for detecting liquid level in a clear or partially clear containerMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2025·Application pending·0 cites
- 0593US11324912B2Systems and methods for indicating lifetime of an NO2-to-NO reactor cartridge used to deliver NO for inhalation therapy to a patientMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2019·Granted May 10, 2022·7 cites·17 claims
- 0692US11471641B2Systems and method for delivery of therapeutic gas to patients in need thereof using enhanced breathing circuit gas (BCG) flow measurementMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2019·Granted Oct 18, 2022·9 cites·19 claims
- 0791US11141549B2Systems and methods for compensating long term sensitivity drift of electrochemical gas sensors exposed to nitric oxideMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2016·Granted Oct 12, 2021·7 cites·17 claims
- 0891US2025114544A1Systems and methods for delivery of therapeutic gasMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 0990US12285008B2Methods to improve organ viabilityMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Granted Apr 29, 2025·0 cites·27 claims
- 1090US11554235B2Apparatus and method for detecting liquid level in a clear or partially clear containerMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2019·Granted Jan 17, 2023·2 cites·8 claims
- 1189US2024316300A1Enhanced performance verification port for therapeutic gas deliveryMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 1286US12491330B2Apparatus and method for detecting liquid level in a clear or partially clear containerMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2023·Granted Dec 9, 2025·0 cites·3 claims
- 1386US11759620B2Use and monitoring of inhaled nitric oxide with left ventricular assist devicesMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2021·Granted Sep 19, 2023·1 cites·5 claims
- 1484US12226572B2Systems and methods for delivery of therapeutic gasMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Granted Feb 18, 2025·0 cites·14 claims
- 1584USD1060405SDisplay screen or portion thereof with graphical user interfaceMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2023·Granted Feb 4, 2025·9 cites·1 claims
- 1681US12415049B2Intelligent gas source managementMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Granted Sep 16, 2025·0 cites·20 claims
- 1781US2024374674A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 1881US2024374676A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 1981US2024374675A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 2081US2024366710A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 2179US12007399B2Method of identifying and treating premature infants at risk for BPDMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Granted Jun 11, 2024·0 cites·6 claims
- 2279US2024399098A1Apparatus and method for monitoring nitric oxide deliveryMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 2379US2024238364A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 2479US2025228235A1Methods to improve orrgan viabilityMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2025·Application pending·0 cites
- 2578US2023201495A1Systems and method for delivery of therapeutic gas to patients, in need thereof, receiving breathing gas from a ventilator that varies at least pressure and/or flow using enhanced therapeutic gas (no) flow measurementMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2023·Application pending·0 cites
- 2677US12052987B2Administration and monitoring of nitric oxide in ex vivo fluidsMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Granted Aug 6, 2024·0 cites·15 claims
- 2776US12257391B2Systems and methods for manufacturing and safety of an NO2-to-NO reactor cartridge used to deliver no for inhalation therapy to a patientMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Granted Mar 25, 2025·0 cites·5 claims
- 2875US12478757B2Compensating for disruptions in breathing gas flow measurementMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Granted Nov 25, 2025·0 cites·15 claims
- 2974USD1120338STherapeutic gas delivery cartMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2025·Granted Mar 24, 2026·0 cites·1 claims
- 3074US2023054888A1Methods and compositions for improving kidney function in patients with hepatorenal syndromeMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Application pending·0 cites
- 3173US11918742B2Apparatus and method for filtering liquid particles from inspiratory gas flow of a patient breathing circuit affiliated with a ventilator and/or nitric oxide delivery systemMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Granted Mar 5, 2024·0 cites·11 claims
- 3273US11529479B2Systems and methods for delivery of therapeutic gasMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2020·Granted Dec 20, 2022·0 cites·9 claims
- 3373US11285280B2Intelligent gas source managementMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2020·Granted Mar 29, 2022·0 cites·13 claims
- 3473US11090454B2Systems and methods for intelligent gas source managementMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2020·Granted Aug 17, 2021·0 cites·30 claims
- 3572US2024390634A1Methods of Reducing the Risk of Mortality Associated With a Medical TreatmentMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 3671US11278696B2Apparatus and method for filtering liquid particles from inspiratory gas flow of a patient breathing circuit affiliated with a ventilator and/or nitric oxide delivery systemMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2020·Granted Mar 22, 2022·0 cites·9 claims
- 3771US11202873B2Enhanced performance verification port for therapeutic gas deliveryMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2019·Granted Dec 21, 2021·0 cites·12 claims
- 3871US2026014235A1Methods of promoting remyelinationMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2025·Application pending·0 cites
- 3970US2023108970A1Methods and compositions for improving kidney function in patients with hepatorenal syndromeMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Application pending·0 cites
- 4070US2023126586A1Methods and compositions for improving kidney function in patients with hepatorenal syndromeMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Application pending·0 cites
- 4169US2022056410A1Method for ex-vivo expansion of regulatory t cells with enhanced suppressive function for clinical application in immune mediated diseasesMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2021·Application pending·0 cites
- 4269US2024307483A1Compositions for improving kidney function in patients with hepatorenal syndromeMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 4368US11474115B2Method of identifying and treating premature infants at risk for BPDMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2020·Granted Oct 18, 2022·0 cites·10 claims
- 4468US11412731B2Administration and monitoring of nitric oxide in ex vivo fluidsMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2020·Granted Aug 16, 2022·0 cites·17 claims
- 4568US2022143132A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Application pending·0 cites
- 4667USD1064285STherapeutic gas delivery cartMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2023·Granted Feb 25, 2025·2 cites·1 claims
- 4767US11291202B2Administration and monitoring of nitric oxide in ex vivo fluidsMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2017·Granted Apr 5, 2022·0 cites·12 claims
- 4867US11124767B2Use of apoptotic cells ex vivo to generate regulatory T cellsMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2018·Granted Sep 21, 2021·0 cites·8 claims
- 4967US2021388318A1Use of apoptotic cells ex vivo to generate regulatory t cellsMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2021·Application pending·0 cites
- 5067US2021290725A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2021·Application pending·0 cites
Showing the top 50 of 82 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when MALLINCKRODT PHARMACEUTICALS IRELAND LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →